BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a viable technique for management of noncompressible torso hemorrhage. The major limitation of the current unilobed fully occlusive REBOA catheters is below-the-balloon ischemia-reperfusion complications. We hypothesized that partial aortic occlusion with a novel bilobed partial (p)REBOA-PRO would result in the need for less intraaortic balloon adjustments to maintain a distal goal perfusion pressure as compared with currently available unilobed ER-REBOA. METHODS: Anesthetized (40-50 kg) swine randomized to control (no intervention), ER-REBOA, or pREBOA-PRO underwent supraceliac aortic injury. The REBOA groups underwent catheter placement into zone 1 with initial balloon inflation to full occlusion for 10 minutes followed by gradual deflation to achieve and subsequently maintain half of the baseline below-the-balloon mean arterial pressure (MAP). Physiologic data and blood samples were collected at baseline and then hourly. At 4 hours, the animals were euthanized, total blood loss and urine output were recorded, and tissue samples were collected. RESULTS: Baseline physiologic data and basic laboratories were similar between groups. Compared with control, interventions similarly prolonged survival from a median of 18 minutes to over 240 minutes with comparable mortality trends. Blood loss was similar between partial ER-REBOA (41%) and pREBOA-PRO (51%). Partial pREBOA-PRO required a significantly lower number of intraaortic balloon adjustments (10 ER-REBOA vs. 3 pREBOA-PRO, p < 0.05) to maintain the target below-the-balloon MAP. The partial ER-REBOA group developed significantly increased hypercapnia, fibrin clot formation on TEG, liver inflammation, and IL-10 expression compared with pREBOA-PRO. CONCLUSION: In this highly lethal aortic injury model, use of bilobed pREBOA-PRO for a 4-hour partial aortic occlusion was logistically superior to unilobed ER-REBOA. It required less intraaortic balloon adjustments to maintain target MAP and resulted in less inflammation.
BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a viable technique for management of noncompressible torso hemorrhage. The major limitation of the current unilobed fully occlusive REBOA catheters is below-the-balloon ischemia-reperfusion complications. We hypothesized that partial aortic occlusion with a novel bilobed partial (p)REBOA-PRO would result in the need for less intraaortic balloon adjustments to maintain a distal goal perfusion pressure as compared with currently available unilobed ER-REBOA. METHODS: Anesthetized (40-50 kg) swine randomized to control (no intervention), ER-REBOA, or pREBOA-PRO underwent supraceliac aortic injury. The REBOA groups underwent catheter placement into zone 1 with initial balloon inflation to full occlusion for 10 minutes followed by gradual deflation to achieve and subsequently maintain half of the baseline below-the-balloon mean arterial pressure (MAP). Physiologic data and blood samples were collected at baseline and then hourly. At 4 hours, the animals were euthanized, total blood loss and urine output were recorded, and tissue samples were collected. RESULTS: Baseline physiologic data and basic laboratories were similar between groups. Compared with control, interventions similarly prolonged survival from a median of 18 minutes to over 240 minutes with comparable mortality trends. Blood loss was similar between partial ER-REBOA (41%) and pREBOA-PRO (51%). Partial pREBOA-PRO required a significantly lower number of intraaortic balloon adjustments (10 ER-REBOA vs. 3 pREBOA-PRO, p < 0.05) to maintain the target below-the-balloon MAP. The partial ER-REBOA group developed significantly increased hypercapnia, fibrin clot formation on TEG, liver inflammation, and IL-10 expression compared with pREBOA-PRO. CONCLUSION: In this highly lethal aortic injury model, use of bilobed pREBOA-PRO for a 4-hour partial aortic occlusion was logistically superior to unilobed ER-REBOA. It required less intraaortic balloon adjustments to maintain target MAP and resulted in less inflammation.
Authors: Juan Duchesne; Todd W Costantini; Mansoor Khan; Ethan Taub; Peter Rhee; Bryan Morse; Nicholas Namias; Alon Schwarz; Joanne Graves; Dennis Y Kim; Erin Howell; Jason Sperry; Vincent Anto; Robert D Winfield; Martin Schreiber; Brandon Behrens; Benjamin Martinez; Shariq Raza; Mark Seamon; Danielle Tatum Journal: J Trauma Acute Care Surg Date: 2019-07 Impact factor: 3.313
Authors: John A Harvin; Tom Maxim; Kenji Inaba; Myriam A Martinez-Aguilar; David R King; Asad J Choudhry; Martin D Zielinski; Sam Akinyeye; S Rob Todd; Russell L Griffin; Jeffrey D Kerby; Joanelle A Bailey; David H Livingston; Kyle Cunningham; Deborah M Stein; Lindsay Cattin; Eileen M Bulger; Alison Wilson; Vicente J Undurraga Perl; Martin A Schreiber; Jill R Cherry-Bukowiec; Hasan B Alam; John B Holcomb Journal: J Trauma Acute Care Surg Date: 2017-09 Impact factor: 3.313
Authors: Aaron M Williams; Umar F Bhatti; Isabel S Dennahy; Nathan J Graham; Vahagn C Nikolian; Kiril Chtraklin; Panpan Chang; Jing Zhou; Ben E Biesterveld; Jonathan Eliason; Hasan B Alam Journal: J Trauma Acute Care Surg Date: 2019-03 Impact factor: 3.313
Authors: Megan L Brenner; Laura J Moore; Joseph J DuBose; George H Tyson; Michelle K McNutt; Rondel P Albarado; John B Holcomb; Thomas M Scalea; Todd E Rasmussen Journal: J Trauma Acute Care Surg Date: 2013-09 Impact factor: 3.313
Authors: Sarah C Stokes; Christina M Theodorou; Scott A Zakaluzny; Joseph J DuBose; Rachel M Russo Journal: J Trauma Acute Care Surg Date: 2021-08-01 Impact factor: 3.697
Authors: James Daley; Ryan Buckley; Kathryn Cannon Kisken; Douglas Barber; Raj Ayyagari; Charles Wira; Ani Aydin; Igor Latich; Juan Carlos Perez Lozada; Daniel Joseph; Angelo Marino; Hamid Mojibian; Jeffrey Pollak; Cassius Ochoa Chaar; James Bonz; Justin Belsky; Ryan Coughlin; Rachel Liu; John Sather; Reinier Van Tonder; Rachel Beekman; Elyse Fults; Austin Johnson; Christopher Moore Journal: J Am Coll Emerg Physicians Open Date: 2022-09-10